SCHEMBL4271735

SCHEMBL4271735

CCCCCC(C)[CH]C(CCCC)CCCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
OPRM1 P35372 1/20 0.42
DNM1 Q05193 2/20 0.39
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
CA1 P00915 2/20 0.35
SPHK1 Q9NYA1 1/20 0.35
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CA2 P00918 1/20 0.33
ACE2 Q9BYF1 1/20 0.32
TRPA1 O75762 1/20 0.32
DDAH1 O94760 1/20 0.32
GAPDH P04406 1/20 0.32
MAPT P10636 1/20 0.32
FDPS P14324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4278671 1.00 TSHR (0.43) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4271864 1.00 TSHR (0.43) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4270233 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4274690 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4277152 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4275524 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4269429 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4271449 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4269423 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B
SCHEMBL4269059 0.98 DNM1 (0.42) TSHRSMN1; SMN2OPRM1DNM1ADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230023-B2 Color converter BASF SE (DE) 2019-03-12 US disclosed
EP-2718395-B1 Novel illumination device comprising a colour converter BASF SE (DE) 2018-02-28 EP disclosed
CN-103619987-B Color converter 巴斯夫欧洲公司 2016-11-16 CN disclosed
US-20160284947-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2016-09-29 US disclosed
US-9406848-B2 Color converter BASF SE (DE) 2016-08-02 US disclosed
EP-2718395-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2014-04-16 EP disclosed
CN-103619987-A Novel color converter BASF SE 2014-03-05 CN disclosed
WO-2012168395-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2012-12-13 WO disclosed
WO-2009037283-A1 METHOD FOR PRODUCING SUBSTRATES COATED WITH RYLENE TETRACARBOLIC ACID DIIMIDES BASF SE (DE) 2009-03-26 WO disclosed
US-20090078312-A1 VERFAHREN ZUR HERSTELLUNG VON MIT RYLENTETRACARBONSAEUREDIIMIDEN BESCHICHTETEN SUBSTRATEN BASF SE (DE) 2009-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090078312-A1 VERFAHREN ZUR HERSTELLUNG VON MIT RYLENTETRACARBONSAEUREDIIMIDEN BESCHICHTETEN SUBSTRATEN AXIN2, NCSTN, NES TSHR 3585/4885SMN1; SMN2 3380/4885OPRM1 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.